---
figid: PMC8210594__thnov11p7491g001
figtitle: Microbial and genetic-based framework identifies drug targets in inflammatory
  bowel disease
organisms:
- Escherichia coli
- Helicobacter pylori
- Salmonella enterica
- Klebsiella pneumoniae
- Enterococcus faecalis
- Bacteroides fragilis
- Clostridium perfringens
- Faecalibacterium prausnitzii
- Enterococcus faecium
- Bifidobacterium animalis subsp. lactis
- Phocaeicola vulgatus
- Lactobacillus acidophilus NCFM
- Salmonella sp.
- Escherichia sp.
- Pseudomonas sp. 16
- Anaerostipes hadrus
- Desulfovibrio fairfieldensis
- gut metagenome
- Meleagris gallopavo
- human metagenome
- Aphyosemion alpha
- Homo sapiens
- Mus musculus
- Oryza sativa
organisms_ner:
- Mus musculus
- Homo sapiens
- Meleagris gallopavo
- Drosophila melanogaster
pmcid: PMC8210594
filename: thnov11p7491g001.jpg
figlink: /pmc/articles/PMC8210594/figure/F1/
number: F1
caption: 'cGAS is Highly Associated with Human IBD. (A) Workflow for the exploration
  of drugs for IBD including three steps: I) target discovery, identify highly inter-correlated
  microbiome-transcriptome interactions by using O2PLS based on the human cohort to
  reveal potential biomarkers in IBD; II) experimental validation, studies on intestinal
  bacteria for functional prediction based on TSEA and transcriptomes for drug screening
  based on LINCS, respectively; III) drug validation, showing the working model of
  brefeldin-a for treatment of IBD. (B) Functional enrichment network of Reactome
  based on the top 200 highly inter-correlated genes. cGAS signaling pathway and downstream
  effectors are highlighted in orange. Each node corresponds to a Reactome term; the
  node''s size is the number of genes annotated to the term. Edges between nodes indicate
  genes shared between Reactome terms. IL, interleukin. (C) cGAS expression levels
  in the rectum. n = 49, 26, 23 independent samples for CD, UC, non-IBD. One-way ANOVA
  with Tukey''s post hoc test determined significance. See also .'
papertitle: Microbial and genetic-based framework identifies drug targets in inflammatory
  bowel disease.
reftext: Zhihan Wang, et al. Theranostics. 2021;11(15):7491-7506.
year: '2021'
doi: 10.7150/thno.59196
journal_title: Theranostics
journal_nlm_ta: Theranostics
publisher_name: Ivyspring International Publisher
keywords: Inflammatory bowel disease | cyclic GMP-AMP synthase (cGAS) | host transcriptome-microbiome
  interaction | drug repurposing | brefeldin-a
automl_pathway: 0.7749434
figid_alias: PMC8210594__F1
figtype: Figure
redirect_from: /figures/PMC8210594__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8210594__thnov11p7491g001.html
  '@type': Dataset
  description: 'cGAS is Highly Associated with Human IBD. (A) Workflow for the exploration
    of drugs for IBD including three steps: I) target discovery, identify highly inter-correlated
    microbiome-transcriptome interactions by using O2PLS based on the human cohort
    to reveal potential biomarkers in IBD; II) experimental validation, studies on
    intestinal bacteria for functional prediction based on TSEA and transcriptomes
    for drug screening based on LINCS, respectively; III) drug validation, showing
    the working model of brefeldin-a for treatment of IBD. (B) Functional enrichment
    network of Reactome based on the top 200 highly inter-correlated genes. cGAS signaling
    pathway and downstream effectors are highlighted in orange. Each node corresponds
    to a Reactome term; the node''s size is the number of genes annotated to the term.
    Edges between nodes indicate genes shared between Reactome terms. IL, interleukin.
    (C) cGAS expression levels in the rectum. n = 49, 26, 23 independent samples for
    CD, UC, non-IBD. One-way ANOVA with Tukey''s post hoc test determined significance.
    See also .'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - 16S
  - Cgas
  - Foxp3
  - Runx1
  - Il2
  - Csf2
  - Il3
  - Il5
  - Il15
  - Il9
  - Kit
  - Il21
  - Ng
  - Lonp1
  - Dnah8
  - sho
  - Cd28
  - Pik3r1
  - Akt1
  - Il1
  - Sting1
  - Ctla4
  - Ppp2ca
  - Ppp2r1a
  - Ier3
  - Il4
  - Il13
  - Il18
  - Nfkb1
  - CGAS
  - FOXP3
  - RUNX1
  - IL2
  - CSF2
  - IL3
  - IL5
  - IL15
  - IL9
  - KIT
  - IL22
  - IL21
  - LONP1
  - DNAH8
  - SPRN
  - CD28
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - IL1B
  - STING1
  - CTLA4
  - PTPA
  - IER3
  - IFNA1
  - COL6A1
  - COL6A2
  - COL6A3
  - COL6A5
  - COL6A6
  - COL7A1
  - COL8A1
  - COL8A2
  - COL9A1
  - COL9A2
  - COL9A3
  - COL10A1
  - COL11A1
  - COL11A2
  - COL12A1
  - COL13A1
  - COL14A1
  - COL15A1
  - COL16A1
  - COL17A1
  - COL18A1
  - COL19A1
  - COL20A1
  - COL21A1
  - COL22A1
  - COL23A1
  - COL24A1
  - COL25A1
  - COL26A1
  - COL27A1
  - COL28A1
  - COL1A1
  - COL1A2
  - COL4A1
  - COL4A2
  - COL4A3
  - COL4A4
  - COL4A5
  - COL4A6
  - COL5A1
  - COL5A2
  - COL5A3
  - IL4
  - IL13
  - IL18
  - IL12A
  - IL12B
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - CDK9
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - blo
  - Lon
  - schlank
  - Vha14-1
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - cd
  - Akt
  - JIL-1
  - Sting
  - aub
  - wrd
  - wdb
  - mts
  - tws
  - Pp2A-29B
  - Dif
  - dl
  - Rel
  - tak
  - Tak1
  - Takl2
---
